Close menu




April 23rd, 2021 | 07:15 CEST

IBM, Revez, Bechtle: Returns thanks to digital transformation

  • Software
Photo credits: pixabay.com

Digitization is here to stay. A recent study by PWC shows, 44% of those surveyed agree that digitization will soon encompass all areas of life. Even if there is rightly a need for discussion in some areas, the trend is intact. The next step will be to digitize the German bureaucracy - an urgently needed step at the latest after the pandemic. Supporting the states and municipalities in this are companies such as IBM. We explain how investors can profit from digitization.

time to read: 2 minutes | Author: Nico Popp
ISIN: US4592001014 , SGXE83751573 , DE0005158703

Table of contents:


    IBM: Major contract as a burden?

    The US company IBM has a big name. Perhaps this is another reason why many public authorities choose the Company as the first contact for everything to do with digitization. In Germany, IBM is to implement electronic prescriptions, making the healthcare system more straightforward and transparent. The contract certainly means an image gain for IBM. But it is not yet clear whether IBM's digitization efforts will end up with only winners - encrusted structures and data protection have already turned many a tiger into a bedside rug in Germany. In other respects, too, things are not going well for IBM. After 9 months, sales recently fell by 4% to USD 53.3 billion. Only the Cloud & Cognitive Software division saw an increase. All other divisions are suffering.

    The infrastructure division is to be spun off into a separate company, to be called Kyndryl - 90,000 employees could then soon no longer work for IBM but a subsidiary. It is doubtful to what extent such measures will help the mood in the group. Given a large number of construction sites in various divisions and the few bright spots, IBM is currently uninteresting for investors - despite or perhaps because of the large order from the German healthcare sector.

    Bechtle: With Swabian power through the pandemic

    The Swabian IT Company Bechtle also works closely with public authorities. The system house with its hardware and software store successfully serves customers from public authorities and small and medium-sized businesses. Bechtle has been growing organically for years and is present mainly in German-speaking countries. Despite the pandemic, sales have continued to rise in recent quarters. The share price dipped a little in the wake of the second wave of infection but is already recovering. On a one-year horizon, the stock has gained just under 30%. There is still room for around 10% for the stock to reach its highs. While cautious investors continue to wait, experienced investors can already get their foot in the door at Bechtle.

    Asian pearl Revez growing steadily

    It can also be worthwhile to be positioned in the Revez share. The Singapore-based company is fully committed to the digital revolution, offering solutions for the public sector and offerings for the tourism, energy, industry and logistics sectors, and media, communications, and virtual events. Revez is also active in the cybersecurity space, announcing a distribution agreement with Israeli specialist Imvision in early April to make data interfaces (API) more secure. "Forward-looking companies need to look at APIs not just as a piece of technology but should build their business models and operational strategies around them. Imvision's AI-based, self-learning architecture creates a new level of digital asset protection for every customer and creates transparency across the API technology stack," said Victor Neo, CEO of Revez.

    Revez's stock has been moving sideways for months on the Singapore stock exchange and Germany, even though the entire Company is valued at only about EUR 26 million, targeting gross margins between 45 and 65% and has steadily increased its revenues over the years. Revez is planning to grow increasingly inorganically because of its positive cash flows and has already been buying on a smaller scale in recent months. The 2020 figures also read positively, with revenue up 17.9% on 2019 to SGD 6.6 million. While the absolute numbers are not yet significant, Revez operates in many interesting areas and is positioned promisingly in Asia. The goal of enabling digital transformation sounds like a promising business area. For investors, it may be worth keeping the stock in mind.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Nico Popp

    At home in Southern Germany, the passionate stock exchange expert has been accompanying the capital markets for about twenty years. With a soft spot for smaller companies, he is constantly on the lookout for exciting investment stories.

    About the author



    Related comments:

    Commented by Stefan Feulner on November 1st, 2022 | 10:59 CET

    SAP, Kleos Space, Palantir - Tech stocks about to take off

    • Space
    • Software
    • cloud

    Whether Amazon, Meta Platforms or Alphabet. Third-quarter figures of the technology giants disappointed across the board, and share prices reached new lows for the year. The Walldorf-based software group SAP presented a completely different picture and surprised investors with better-than-expected sales figures. In the next few weeks, it is mainly second-tier technology stocks that could provide positive surprises. Due to the strong correction of the past months, a trend reversal could be heralded in the long term.

    Read

    Commented by Fabian Lorenz on May 6th, 2022 | 11:49 CEST

    TeamViewer, Nel, mm2 Asia: Analysts see upside potential

    • entertainment
    • Hydrogen
    • Software

    The US Federal Reserve raised key interest rates by 0.5 percentage points on Wednesday to counteract rapidly rising inflation. After falling sharply in the run-up to the move, share prices worldwide subsequently rallied again. Yesterday, the DAX was back above 14,000 points. Analysts also commented positively on selected shares. For example, TeamViewer's quarterly figures were a positive surprise and analysts see significant upside potential. Goldman Sachs even sees a price potential of over 50% for Nel, and the hydrogen specialist has also landed the next order. However, more has to come. And in the case of the Asian media and technology company mm2 Asia, analysts see even more than 100% share price potential - partly due to the NFT marketplace. Elon Musk has now also discovered the hype surrounding NFTs for himself.

    Read

    Commented by André Will-Laudien on April 6th, 2022 | 10:46 CEST

    Siemens Healthineers, Perimeter Medical, Siemens, SAP - After BioNTech, now the push for MedTech shares!

    • medtech
    • Biotechnology
    • Software

    The most significant positive share price developments in the last 12 months occurred in the biotech sector, especially among vaccine manufacturers such as BioNTech and Moderna. The stock market overlooked that pandemics, and the fight against them, offer short-term profit opportunities. The great battle against widespread diseases such as cardiovascular disease, cancer or other previously incurable indications progresses steadily. Their diagnosis and treatment require many types of technology, devices, processes, analysis tools, and intelligent software. Some methods certainly deserve the attribute "disruptive technology". We take a look at some blockbusters in the MedTech segment.

    Read